2025-12-13 - Analysis Report
Okay, let's break down this analysis of Procter & Gamble (PG).

**0) Overview**

Procter & Gamble (PG) is a multinational consumer goods corporation focusing on a wide range of branded products.

**1) Return Rate Comparison vs. S&P 500 (VOO)**

*   **PG Cumulative Return:** 22.31%
*   **VOO Cumulative Return:** 102.37%
*   **Divergence:** -72.5
*   **Relative Divergence:** 1.5

**Analysis:**  PG has significantly underperformed the S&P 500. The divergence of -72.5 indicates a substantial difference in returns, and the relative divergence of 1.5 suggests that this divergence is currently near its historical low.

**Alpha, Beta Analysis Table:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 21.0% | 7.9% | -8.0% | 0.0 | 219.7 |
| 2016-2018  | 9.0% | 67.3% | -6.0% | 0.1 | 219.8 |
| 2017-2019  | 24.0% | 70.4% | 2.0% | 0.3 | 298.6 |
| 2018-2020  | 27.0% | 78.8% | 4.0% | 0.4 | 332.7 |
| 2019-2021  | 41.0% | 78.8% | -5.0% | 0.5 | 391.1 |
| 2020-2022  | 13.0% | 79.4% | 13.0% | 0.6 | 362.4 |
| 2021-2023  | 26.0% | 79.4% | 24.0% | 0.4 | 350.4 |
| 2022-2024  | 9.0% | 79.4% | -12.0% | 0.4 | 400.9 |
| 2023-2025  | -22.0% | 80.1% | -89.0% | 0.2 | 334.3 |

*   **CAGR (Compound Annual Growth Rate):**  Fluctuating growth, with a significant decline in the most recent period (2023-2025).
*   **MDD (Maximum Drawdown):**  MDD has increased in recent years, suggesting heightened risk of significant losses.
*   **Alpha:**  Alpha is mostly negative, implying underperformance relative to its benchmark (risk-adjusted). The latest period shows a dramatic decrease in Alpha.
*   **Beta:**  Beta is low (around 0.2-0.6), indicating lower volatility than the overall market.
*   **Cap (B):** Market capitalization has fluctuated.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 139.82
*   **Last Market Data:** Price: 142.84, Previous Close: 140.76, Change: 1.48
*   **5-day SMA:** 141.32
*   **20-day SMA:** 146.05
*   **60-day SMA:** 149.36

**Analysis:** The stock price is currently below all three moving averages (5, 20, and 60 day). This suggests a potential short-term and medium-term downtrend.  The recent price increase in 'Last Market Data' indicates a short-term rebound.

**3) RSI, PPO and other indicators**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 34.21 (Approaching oversold territory)
*   **PPO:** -0.56 (Bearish trend)
*   **Hybrid Signal:** Buy 100% (Very Safe - MRI: 0.90) - This signal suggests a bullish outlook based on the MRI.
*   **Recent Divergence Change:** -3.1 (Short-term Decline)
*   **Expected Return:** 82.9% (High Expected Return)

**Analysis:** The RSI suggests the stock might be oversold, potentially leading to a price correction. The PPO indicates a bearish trend.  The hybrid signal offers a conflicting view, recommending a buy based on its risk model.

**4) Recent News & Significant Events**

*   **Negative Sentiment:** Many headlines point to price declines and lowered expectations (e.g., "Procter & Gamble Drops 11.9% in 3 Months," "Deutsche Bank Aktiengesellschaft Has Lowered Expectations").
*   **Mixed Opinions:** Some articles suggest potential value ("The Dividend King Is On Sale Now"), while others advise caution ("Buy the Dip or Stay Wary?").
*   **Earnings Focus:**  Articles discuss Q1 FY26 earnings and price decline.
*   **Analyst Forecasts:**  Focuses on analysts' forecasts and what's next for the stock.

**Analysis:** The news sentiment appears mixed to negative. The focus on price declines and lowered expectations suggests market concerns.  However, some articles highlight the dividend yield as a potential positive.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.00)
*   **Target Price:** Avg: 168.73, High: 186.00, Low: 148.00

**Analysis:** Despite the negative news flow, analysts, on average, maintain a "Buy" rating with a target price significantly higher than the current price, suggesting potential upside.

**5) Recent Earnings Analysis**

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-10-24 | 2     | 22.39 B$   |
| 2025-04-24 | 1.58  | 19.78 B$   |
| 2025-01-22 | 1.94  | 21.88 B$   |
| 2024-10-18 | 1.65  | 21.74 B$   |
| 2025-10-24 | 1.65  | 21.74 B$   |

**Analysis:** EPS and revenue show some fluctuation. Most recent quarter shows an EPS of 2 and 22.39B$ in revenue, a relative increase.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $22.39B    | 51.37%        |
| 2025-06-30   | $20.89B    | 49.11%        |
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-09-30   | $53.27B    | 8.92%  |
| 2025-06-30   | $52.01B    | 6.95%  |
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |

**Analysis:** Revenue has fluctuated, with the most recent quarter showing a positive trend. Profit margins are consistently high (around 50%), indicating strong pricing power and cost management. Equity has been growing. ROE has fluctuated, showing recent positive trend.

**7) Comprehensive Analysis**

Procter & Gamble has underperformed the broader market (S&P 500) significantly.  The stock price is currently in a short-term and medium-term downtrend, though it is showing recent signs of a rebound. The RSI indicates the stock may be oversold. Recent news sentiment is mixed to negative, with concerns about price declines. However, analysts maintain a "Buy" rating with a substantial price target, offering a conflicting outlook. Financially, PG demonstrates relatively consistent revenue and strong profit margins.

**In summary:** While the stock faces short-term challenges, strong fundamentals and analyst optimism suggests potential for long-term recovery. The high expected return also reinforces this idea, but be aware of the higher maximum drawdown and lower Alpha values. The divergent signals from the indicators highlight the need for cautious optimism and further research.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.